Trademarkia Logo

Canada

C$
Trademark Search in Canada
CANCERNEXT

View On IC.GC.CA

CANCERNEXT
REGISTERED

on 13 Jan 2015

Last Applicant/ Owned by

AMBRY GENETICS CORPORATION A DELAWARE CORPORATION

1 Enterprise,Aliso Viejo, California 92656

US

Serial Number

1591399 filed on 23rd Aug 2012

Registration Number

TMA893844 registered on 13th Jan 2015

Registration expiry Date

13th Jan 2030

Correspondent Address

RICHES, MCKENZIE & HERBERT LLP

SUITE 18002 BLOOR STREET EASTTORONTO

ONTARIO

CA

M4W3J5

CANCERNEXT

Trademark usage description

medical screening; medical testing services for diagnostic and treatment purposes; dna analysis services for medical purposes; medical administrative Read More

Classification Information

Class [001]
Chemicals and adhesives

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [035]
Advertising, marketing, promotional and business

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Computer and scientific

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [044]
Medical and veterinary, beauty, agricultural and forestry

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

1591399

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 57
on 26th Nov 2019		Amendment to Registration
Submitted for opposition 57
on 3rd Mar 2015		Amendment to Registration
Submitted for opposition 55
on 13th Jan 2015		Registered
Submitted for opposition 51
on 5th Dec 2014		Allowance Notice Sent
Submitted for opposition 50
on 5th Dec 2014		Allowed
Submitted for opposition 42
on 20th Aug 2014		Advertised
Submitted for opposition 26
on 31st Jul 2014		Approved
Submitted for opposition 27
on 10th Jun 2014		Approval Notice Sent
Submitted for opposition 12
on 22nd Oct 2013		Extension of Time
Submitted for opposition 20
on 26th Feb 2013		Examiner's First Report